Abnormalities, Multiple: Clinical Trials

5 trials for Abnormalities, Multiple, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 withdrawn. 5 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 35Withdrawn 5
Phase 21Withdrawn 1

Follow Abnormalities, Multiple: new trials by email Literature Review of Abnormalities, Multiple trials Research Report on Abnormalities, Multiple

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 3 Extension Study of RAD011 (Cannabidiol Oral Solution) in Patients With Prader-Willi Syndrome
RAD011 - Prader-Willi Syndrome
Phase 3WithdrawnRadius Pharmaceuticals, Inc.2023-01-012022-10-06
A Study to See if Tolvaptan Can Delay Dialysis in Infants and Children Who at Enrollment Are 28 Days to Less Than 12 Weeks Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)
Tolvaptan (OPC-41061) - Autosomal Recessive Polycystic Kidney Disease (ARPKD)
Phase 3WithdrawnOtsuka Pharmaceutical Development & Commercialization, Inc.2022-07-012025-12-24
An Open-Label Study of DCCR Tablet in Patients With PWS
DCCR - Prader-Willi Syndrome
Phase 3WithdrawnSoleno Therapeutics, Inc.2019-10-012021-08-03
Circulating Transforming Growth Factor Beta (TGF-β) in Individuals With Marfan Syndrome
Blood draw - Marfan Syndrome
Phase 3WithdrawnAnn & Robert H Lurie Children's Hospital of Chicago2011-04-012016-02-05
Efficacy, Safety and Tolerability of Topically Applied LDE225 Cream (Hedgehog Pathway Inhibitor) in Adult Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS)
LDE225B, Vehicle - Basal Cell Carcinoma
Phase 2 / Phase 3WithdrawnNovartis Pharmaceuticals2017-05-05

Narrower conditions

Prader-Willi Syndrome (2)  ·  Basal Cell Nevus Syndrome (1)  ·  Carcinoma, Basal Cell (1)  ·  Marfan Syndrome (1)  ·  Oligohydramnios (1)  ·  Polycystic Kidney Diseases (1)  ·  Polycystic Kidney, Autosomal Recessive (1)

Broader conditions

Congenital Abnormalities (5)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5)  ·  Genetic Diseases, Inborn (5)  ·  Bone Diseases (2)  ·  Bone Diseases, Developmental (2)  ·  Chromosome Disorders (2)  ·  Imprinting Disorders (2)  ·  Intellectual Disability (2)  ·  Musculoskeletal Diseases (2)  ·  Nervous System Diseases (2)  ·  Neurobehavioral Manifestations (2)  ·  Neurologic Manifestations (2)  ·  Nutrition Disorders (2)  ·  Nutritional and Metabolic Diseases (2)

Interventions

Blood Specimen Collection (1)  ·  Tolvaptan (1)

Sponsors

Ann & Robert H Lurie Children's Hospital of Chicago (1)  ·  Novartis Pharmaceuticals (1)  ·  Otsuka Pharmaceutical Development & Commercialization, Inc. (1)  ·  Radius Pharmaceuticals, Inc. (1)  ·  Soleno Therapeutics, Inc. (1)

Countries

Belgium (1)  ·  Canada (1)  ·  Czechia (1)  ·  Finland (1)  ·  Germany (1)  ·  Greece (1)  ·  Italy (1)  ·  Spain (1)  ·  Switzerland (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Olga Sergeyeva, MD (1)